In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Biopharma In 2014: Early Access Gains Offset Taxation, Pricing Woes

Executive Summary

The year was marked by record levels of biopharma M&A activity and a strong IPO market. Measures designed to deliver early access to new medicines continued to advance on both sides of the Atlantic, while pricing came in for renewed attention as new, highly effective but extremely expensive products reached the market.

Advertisement

Related Content

Medtech 2014: M&A, IPOs Bounce Back As Industry Glimpses Future Business Models
Diagnostics In 2014: More Of The Same
Medtech In 2014: M&A, IPOs Bounce Back As Industry Glimpses Future Business Models
After A Gargantuan Year For Pharma M&A, More To Come In 2015
Beyond "Breakthrough": FDA, Industry See Benefits For Drugs Outside Expedited Pathway
Antibiotics: Officially Encouraged, Increasingly Precise, Still Risky
Lessons From The First Biosimilar MAb Launch In Europe
Adaptive Licensing: Industry On Board, With Caveats
A Banner Year For Pharma: M&A Tops 2009 Merger Mania
The UK’s Early Access Scheme: Breakthrough Or Mixed Blessing?

Topics

Related Companies

Related Deals

Advertisement
UsernamePublicRestriction

Register

IV004288

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel